Welcome to our dedicated page for Cycurion SEC filings (Ticker: CYCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cycurion, Inc. filings document material-event disclosures for an emerging growth company operating in AI-driven cybersecurity and information technology services. Recent 8-K reports furnish press releases and exhibits covering customer contract awards, operating and financial updates, shareholder communications, acquisition-related disclosures, legal proceedings, and other corporate events.
The company's regulatory record also includes governance disclosures such as board changes, amendments to prior 8-K reports, capital-structure references involving common stock and warrants, and securityholder-facing information tied to its public-company status. These filings frame Cycurion's contract-based revenue model, cybersecurity platforms, legal matters, and corporate actions in formal SEC disclosure.
Cycurion, Inc. reported a strategic business reorganization aimed at streamlining operations, improving agility, and supporting long-term growth in its cybersecurity business. The company expects approximately $2.2 million in total annualized cost efficiencies in 2026 from changes across personnel, operational, and administrative areas, while seeking to preserve service quality and client-facing capabilities.
Cycurion is also focusing on innovation in cloud security, AI-driven risk management, and infrastructure protection, including continued development of its AI-powered ARx platform. In connection with the reorganization, Cycurion appointed Rick Finfera as Chief Revenue Officer to lead global sales strategy, expand client relationships, and drive revenue growth.
Cycurion, Inc. filed a current report to share a press release about new third‑party analyst coverage from Litchfield Hills Research, which initiated CYCU with a Buy rating and a $7.00 price target. The report cites Cycurion’s $80 million contracted backlog, described as roughly four times fiscal 2024 revenue, and current annual revenue of $15.67 million as drivers of expected 2026 growth.
The press release notes InvestingPro data showing an estimated market capitalization of $10.68 million, a Price/Book ratio of 0.53, and high share‑price volatility with the stock down 78.2% over six months. Litchfield Hills compares a valuation of 2.9x estimated 2026 revenue at the $7 target to a stated peer average of 9.0x. Cycurion engaged and paid Litchfield Hills to prepare the research but emphasizes the firm’s editorial independence and that the report is not investment advice.
Cycurion, Inc. is asking stockholders to approve the issuance of up to 3,314,920 shares of common stock upon exercise of warrants issued in a December 2025 private placement, as required by Nasdaq Listing Rule 5635(d).
As of January 21, 2026, Cycurion had 4,188,187 shares of common stock and 960,224 as-if-converted preferred voting shares outstanding. The warrants will only become exercisable for five years after stockholders approve this proposal. A second proposal would allow adjournment of the special meeting to solicit more votes if needed. The board unanimously recommends voting in favor of both proposals, noting that approval would enable potential warrant exercises to help fund operations, while non-approval could force repeated special meetings and increase costs.
Cycurion, Inc. filed a current report to note that it issued a press release on January 22, 2026, which is furnished as Exhibit 99.1. The company’s common stock trades on Nasdaq under “CYCU,” and its redeemable warrants trade under “CYCUW,” each warrant exercisable for one common share at an exercise price of $345.00 per share. Cycurion is identified as an emerging growth company, and the report is signed by Chief Executive Officer L. Kevin Kelly.
Cycurion, Inc. is calling a special shareholder meeting on February 26, 2026 to approve the issuance of up to 3,314,920 shares of common stock upon exercise of warrants issued in a December 5, 2025 private placement. Because this potential issuance may exceed 20% of shares outstanding, Nasdaq Listing Rule 5635(d) requires shareholder approval before the warrants can be exercised.
If approved, the warrants become exercisable for five years at an initial price of $3.62 per share, providing a potential source of funding but also meaning meaningful dilution if fully exercised. As of January 21, 2026, Cycurion had 4,188,187 common shares outstanding and an additional 501,224 voting-equivalent preferred shares. A second proposal would allow the meeting to be adjourned to gather more votes if needed.
Cycurion, Inc. updated the distribution ratio for its previously announced special stock dividend of CYCU shares valued at $500,000.
Shareholders of record as of December 15, 2025 will now receive 0.0180 CYCU common shares for every existing CYCU common share on a fully diluted basis, with the dividend payable on or about December 30, 2025.
Cycurion, Inc., a Delaware-based company listed on The NASDAQ Stock Market, filed an update to report that it issued a press release on December 5, 2025, which is furnished as Exhibit 99.1 under an “Other Events” section. The company’s listed securities include common stock trading under the symbol CYCU and redeemable warrants trading under CYCUW, with each warrant exercisable for one share of common stock at an exercise price of $345.00 per share.
Cycurion, Inc. is registering 7,000,000 shares of common stock for primary issuance under an equity purchase agreement with Yield Point NY LLC and several additional share classes for resale by existing holders. The resale portion covers 119,326 outstanding shares of common stock, 395,866 shares underlying warrants, up to 83,333 shares underlying a pre-funded warrant for Seward & Kissel LLP, and 696,146 shares issuable upon conversion of 3,133 shares of Series G Convertible Preferred Stock. Under the equity purchase agreement, Cycurion may direct Yield Point to buy up to $60 million of stock at 90% of the lowest three-day VWAP, with 25,000,000 authorized shares reserved to support potential draws. The company recently implemented a 1-for-30 reverse stock split effective October 27, 2025, and warns that issuances under the facility could be highly dilutive and pressure its Nasdaq-listed share price.
Cycurion, Inc. has filed a Form S-1 registering a primary offering of up to 7,000,000 shares of common stock that may be issued to Yield Point NY LLC under an Equity Purchase Agreement, an equity line that permits the company to sell shares at 90% of the lowest three‑day VWAP after each put notice, with capacity of up to $60 million in stock sales subject to conditions and future registration. The S-1 also registers secondary resales by selling stockholders of existing common shares, shares underlying public and PIPE warrants, a pre-funded warrant and shares issuable upon conversion of Series G Convertible Preferred Stock, from which the company generally will not receive proceeds other than any cash warrant exercises. The prospectus explains a 1‑for‑30 reverse stock split effective October 27, 2025, outlines Cycurion’s cybersecurity services business and recent Nasdaq notifications confirming compliance with stockholders’ equity and market value listing requirements, and highlights significant risks including dilution, recurring losses, substantial doubt about continued going concern, need for additional funding and potential stock price volatility.
Cycurion (CYCU) filed its Q3 2025 10‑Q, reporting quarterly net revenues of $3,833,038 and a net loss attributable to Cycurion of $3,123,317. For the nine months, revenue reached $11,591,003 with a net loss of $18,560,558, driven by higher operating expenses and business combination costs.
The company disclosed substantial doubt about its ability to continue as a going concern, citing an accumulated deficit of $21.8M, a working capital deficit of $9.6M, and operating cash outflow of $8.77M for the nine months, all as of September 30, 2025. Cash and cash equivalents were $3,652,074 at period end.
Cycurion completed a reverse recapitalization with Western Acquisition Ventures in February 2025 and consolidated SLG Innovation under a Management Services Agreement, recording goodwill. The company executed a 1‑for‑30 reverse stock split effective October 27, 2025 and subsequently announced that it regained compliance with Nasdaq’s Bid Price Rule, avoiding delisting. Common shares outstanding were 2,712,489 as of November 7, 2025.